仑伐替尼联合TACE辅助治疗术后高复发风险肝细胞癌患者: LANCE研究结果更新

    Adjuvant Lenvatinib in Combination With TACE for HCC Patients With High Risk of Postoperative Relapse: Updated of LANCE Study

    /

    返回文章
    返回